Determination of ceftazidime concentration in Mueller Hinton agar by high-performance liquid chromatography

Journal of Chromatography A

Volumn 742, Issue 1-2, 1996, Pages 121-126

  Arcelloni, Cinzia ^a   Basile, Monica ^b   Vaiani, Roberto ^b   Bonini, Pierangelo ^b   Paroni, Rita ^a  

^a IRCCS H S Raffaele   (Italy)

^b NONE   (Italy)

Author keywords

Antibiotics; Ceftazidime; Muellar Hinton agar

Indexed keywords

AGAR; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME;

ARTICLE; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0030599007     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9673(96)00181-1     Document Type: Article

References (23)

1. [1] A.W. Bauer, W.M.M. Kirby, J.A. Sherris and M.D. Turck, Am. J. Clin. Pathol., 45 (1966) 493.
2. [2] J.F. Acar and F.W. Goldstein, in V. Lorian (Editor), Antibiotics in Laboratory Medicine, The Williams and Wilkins Co., Baltimore, MD, 1991, Ch. 2, p. 17.
3. [3] I. Hoette and A.P. Struyk, J. Lab. Clin. Med., 51 (1958) 638.
4. [4] S. Aldous, J. Carpenter and K. Thomson, J. Microbiol. Meth., 4 (1985) 195.
5. [5] J.A. McAteer, M.F. Hiltke, B.M. Silber and R.D. Faulkner, Clin. Chem., 33 (1987) 1788.
6. [6] E.M. McCormick, R.M. Echols and T.G. Rosano, Antimicrob. Agents Chemother., 25 (1984) 336.
7. [7] S.A. Signs, T.M. File and J.S. Tan, Antimicrob. Agents Chemother., 26 (1984) 652.
8. [8] A.J. Baskerville, D. Felmingham and R.N. Gruneberg, Drug. Exptl. Clin. Res., 14 (1988) 645.
9. [9] M. Bliss and M. Mayershon, Clin. Chem., 32 (1986) 197.
10. [10] K. Chapin-Robertson and S.C. Edberg, in V. Lorian (Editor), Antibiotics in Laboratory Medicine, The Williams and Wilkins Co., Baltimore, MD, 1991, Ch. 10, p. 337.
11. [11] T.A. Emm, J. Leslie, M. Chai, L.J. Lesko, and M.B. Perkal, J. Chromatogr., 427 (1988) 162.
12. [12] G.G. Granich and D.J. Krogstad, Antimicrob. Agents Chemother, 31 (1987) 385.
13. [13] R.H. Rumble and M.S. Roberts, J. Chromatogr., 419 (1987) 408.
14. [14] R.D. Toothaker, D. S. Wright and L.A. Pachla, Antimicrob. Agents Chemother., 31 (1987) 1157.
15. [15] J.S. Leeder, M. Spino, A.M. Tesoro and S.M. MacLeod, Antimicrob. Agents Chemother., 24 (1983) 720.
16. [16] C.Y. Chan, K. Chan and G.L. French, J. Antimicrob. Chemother., 18 (1986) 537.
17. [17] A.M. Brisson and J.B. Fourtillan, J. Chromatogr., 223 (1981) 393.
18. [18] C.E. Fashing, L.R. Peterson, K.M. Bettin and D.N. Gerding, Antimicrob. Agents Chemother. 22 (1982) 336.
19. [19] J.D.C. Yao and R.C. Moellering Jr., in P.R. Murray (Editor), Manual of Clinical Microbiology, American Society for Microbiology, Washington D.C., 6th ed., 1995, Ch. 111, p. 1281.
20. [20] D.S. Reeves, H.A. Holt and M.J. Bywater, Infection, 11 (1983), S3.
21. [21] A.L. Barry, in A.L. Barry (Editor), The Antimicrobic Susceptibility Test: Principles and Practices, Lea and Febiger, Philadelphia, 1976, Ch. 13, p. 163.
22. [22] M. Uihlein, N. Klesel and K. Seeger, Infection, 16 (1988) 135.
23. [23] National Committee for Clinical Laboratory Standards (NCCLS), 1993. Performance standards for antimicrobial disk susceptibility tests. Approved Standards M2-A5. National Committee for Clinical Laboratory Standards, Villanova, PA.